Title: Regenerative therapy for ligaments, tendons and meniscus injuries. Current evidence

Abstract:

Ligaments, tendons and meniscus are among the most common sports injuries with poor healing potential. Persistent symptoms and limited function have serious impact on sports carrier.Current treatment is mainly limited to symptom relieve which results in chronicity and incomplete healing. Regenerative medicine is evolving medical science offering possibility to shift our scope from “care” to “cure”. In its theoretical concept it brings the hope that impaired tissue can be regenerated and functional as before the injury. The most common form of regenerative therapy in sports medicine is direct injections to the damaged tissue. The ingredients with possible regenerative potential that are recently used are dextrose (the treatment is called prolotherapy), platelet rich plasma (PRP) and mesenchymal stem cells (MSc).By searching the literature and current evidence we will try to answer three important questions related to regeneration of ligaments, tendons and meniscus :

1. Do regenerative injections provide long term symptoms relieve?
2. Are there verified structural changes in injected tissues after the treatment?
3. Does regenerative therapy reduce the time to return to play?

 The future of regenerative medicine based on current research will be elaborated in detail.

Biography:

Suad Trebinjac graduated from Medical Faculty University of Sarajevo on 3/25/82 with entrance date 9/1/74. The school is in Sarajev. Dr. Suad Trebinjac's specialty is Physical Medicine and Rehabilitation and currently works as a Physician. He is working as Associate professor in Dubai Medical College for Girls. The first Prolotherapy’s in Middle East (training in the University of Wisconsin-USA)